Preferential Issue

Fund Raising View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

—Next day

₹24.70

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.6%—

Diversified Commercial Services peers, median of 70sector-0.6%—

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

—-0.7—-0.5—

Next day

—-0.6—-0.6—

—-2.5—-1.7—

+5.0-4.2+9.2-3.3+8.2

+10.2-5.1+15.3-4.5+14.7

+15.7-4.7+20.4-4.3+20.1

—-5.1—-4.1—

15d

+79.3-8.6+87.9-10.4+89.7

+151.8-5.2+157.0-6.8+158.6

+61.1-10.5+71.6-13.4+74.6

—-12.0—-15.4—

UpDownMarket · Nifty Microcap 250Sector · Diversified Commercial Services peers, median of 70Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sanchay Finvest Ltd's board approved a preferential allotment of 48.5 lakh equity shares at Rs. 10 per share (face value), raising up to Rs. 4.85 crore. All five proposed allottees are non-promoter individuals (Rushabh Praful Satra, Vrutika Praful Satra, Anil Babubhai Mehta, Shankar Dayal Singh, and Saumya Singh), each with NIL pre-holding in the company. To accommodate this issue, the company plans to increase its authorized capital from Rs. 8 crore to Rs. 12 crore, subject to shareholder approval. An Extraordinary General Meeting has been scheduled for February 5, 2026 to seek member approval. The board also approved shifting the registered office from Madhya Pradesh to Maharashtra.

Likely market impact

Since shares are being issued at face value to new non-promoter investors, existing shareholders will face dilution of their stake without receiving any fresh capital themselves. The Rs. 4.85 crore raise is relatively small, and details on the end-use of funds were not disclosed in this filing, which may raise questions about the purpose of the capital infusion.